Ipsen To Exit Consumer Health And Focus On Specialty Pharma
In Talks To Sell Unit For €350m
Executive Summary
The French group is sharpening its focus on specialty care in oncology, rare disease and neuroscience, so is looking to divest its consumer health division to Mayoly Spindler.